Walleye Capital
AVNS

Walleye Capital’s Avanos Medical AVNS Stock Holding History

Walleye Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,848
Closed -$447K – 4380
2025
Q4 		$447K Buy
+39,848
New +$456K ﹤0.01% 3026
2025
Q3 		– Sell
-64,213
Closed -$786K – 4479
2025
Q2 		$786K Sell
64,213
-1,390
-2% -$17.5K ﹤0.01% 2246
2025
Q1 		$940K Buy
+65,603
New +$1.02M ﹤0.01% 2020
2024
Q3 		– Sell
-14,703
Closed -$293K – 5273
2024
Q2 		$293K Sell
14,703
-16,460
-53% -$321K ﹤0.01% 3994
2024
Q1 		$620K Buy
+31,163
New +$602K ﹤0.01% 3012
2023
Q4 		– Sell
-16,787
Closed -$339K – 4926
2023
Q3 		$339K Buy
+16,787
New +$381K ﹤0.01% 3130

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Walleye Capital's AVNS Position: Q1 2026 in Review

Walleye Capital sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 39,848 shares — an estimated $447K sold.

Walleye Capital first reported a position in AVNS in Q3 2023 and held it in 6 quarters. The position peaked at $940K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Walleye Capital reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 39,848 Avanos Medical shares in Q1 2026, an estimated $447K.
  • Walleye Capital first reported a position in Avanos Medical in Q3 2023 and held it in 6 quarters.
  • Walleye Capital's Avanos Medical position peaked at $940K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.